Amunix Pharmaceuticals

North America Legal Chronicle. December 23, 2021

Sanofi’s Pending Acquisition of Amunix

By Martina Bellini

Fenwick & West advised Amunix on the deal, while Weil, Gotshal & Manges advised Sanofi. Amunix, an immuno-oncology company, announced its pending acquisition by Sanofi, a global...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Alcon Inc’s Acquisition of LENSAR Inc

PPG Industries’ €900 Million Notes Offering

Celanese’s $2.6 Billion Senior Notes Offering and Concurrent Cash Tender Offer

Caixa Seguridade Participações’ R$1.2 Billion Common Stock Offering

NEOOH’s Acquisition of Wide Digital

Horta da Terra’s Investment Round

Séché Environnement’s €400 Million High Yield Offering

Gamma Capital Markets’ Establishing New Fund Called ELTIF Unicorn Renewables

Hermes Airports’ Phase 2 Expansion Works

2PointZero’s Acquisition of Maseera Holding

Hyde Park Developments’ EGP2.6 Billion Medium-Term Financing

SolarAfrica Energy’s Financing of 114 MW SunCentral 1 PV Plant and Main Transmission Substation

Entaj’s US$120 Million Initial Public Offering

SALIC’s US$1.78 Billion Acquisition of Additional Stake in Olam Agri

Hassana Investment Company’s Acquisition of 40% Stake in Berain Water Company

Hindustan Unilever’s Investment in Lucro

Multiplex Association of India & Anr v. State of Karnataka & Ors

Clifford Capital’s S$500 Million Notes Offering

What Is the Average Bicycle Accident Claim?

Nelson Wilians Advogados advises on structuring innovative CRI with tokenization potential

Cleary Gottlieb Acquires Springbok AI

Tarter Krinsky & Drogin Adds Seasoned Transactional Partner Richard DiStefano to Strengthen Firm’s Corporate Practice

Buchalter Welcomes New Shareholder in Atlanta

Linklaters Announces New Partners and Counsels Promotions

Sanofi’s Pending Acquisition of Amunix

Standard 1 Year Membership Required